FDA Launches AI Tool to Accelerate Drug Reviews and Inspections
“Elsa” is available to all FDA employees, enabling faster clinical protocol reviews, shortened scientific evaluations, and improved identification of high-priority inspection targets. In one case, a review that would have taken 2-3 days was completed in just 6 minutes.